Chemoinformaics analysis of 1,16-DIBROMOHEXADECANE
| Molecular Weight | 384.24 | nRot | 15 |
| Heavy Atom Molecular Weight | 351.984 | nRig | 0 |
| Exact Molecular Weight | 382.087 | nRing | 0 |
| Solubility: LogS | -7.066 | nHRing | 0 |
| Solubility: LogP | 8.278 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 54.1574 |
| nHD | 0 | BPOL | 34.8626 |
| QED | 0.206 |
| Synth | 1.553 |
| Natural Product Likeliness | 0.074 |
| NR-PPAR-gamma | 0.371 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -4.935 |
| MDCK | 0.00000828 |
| BBB | 0.087 |
| PPB | 0.976211 |
| VDSS | 3.688 |
| FU | 0.0202083 |
| CYP1A2-inh | 0.251 |
| CYP1A2-sub | 0.188 |
| CYP2c19-inh | 0.353 |
| CYP2c19-sub | 0.06 |
| CYP2c9-inh | 0.117 |
| CYP2c9-sub | 0.928 |
| CYP2d6-inh | 0.287 |
| CYP2d6-sub | 0.129 |
| CYP3a4-inh | 0.192 |
| CYP3a4-sub | 0.046 |
| CL | 2.177 |
| T12 | 0.062 |
| hERG | 0.302 |
| Ames | 0.526 |
| ROA | 0.407 |
| SkinSen | 0.952 |
| Carcinogencity | 0.191 |
| EI | 0.987 |
| Respiratory | 0.947 |
| NR-Aromatase | 0.311 |
| Antiviral | Yes |
| Prediction | 0.737995 |